Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13Rectal Neoplasms 10Esophageal Neoplasms 7Colorectal Neoplasms 7Stomach Neoplasms 6Esophageal Squamous Cell Carcinoma 6Uterine Cervical Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma Of Esophagus 5Squamous Cell Carcinoma of Head and Neck 4Neuroblastoma 4Neoplasm Metastasis 4Nasopharyngeal Carcinoma 4Colonic Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Lung Neoplasms 3Liposarcoma 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Prostatic Neoplasms 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Multiple Myeloma 2Melanoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2

Interventions

Gemcitabine 18Cisplatin 13Oxaliplatin 8Capecitabine 7Leucovorin 6Fluorouracil 5pembrolizumab 4Photochemotherapy 3Irinotecan 3ivosidenib 2Cholangiopancreatography, Endoscopic Retrograde 2zanidatamab 1toripalimab 1pemigatinib 1lenvatinib 1infigratinib 1durvalumab 1cemiplimab 1becatecarin 1atezolizumab 1Tissue Adhesives 1Tegafur 1Taxes 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiation 1Platinum 1Pancreaticojejunostomy 1Nivolumab 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cholangiocarcinoma × Neoadjuvant Therapy × Clear all
NCT02773485 2022-10-21

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Tata Memorial Hospital

Phase 3 Unknown
155 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡